About MabThera®
MabThera® (rituximab) provides a fundamentally different treatment approach for rheumatoid arthritis (RA) and has an established efficacy and safety profile based on several clinical trials (Cohen et al. 2006; Cohen et al. 2010; Emery et al. 2006; Edwards et al. 2004; van Vollenhoven et al, 2010). If you would like to know more about MabThera this section of the website contains a wealth of useful information:
- Key scientific and clinical milestones in the development of MabThera for treatment of RA
- Details of the MabThera mode of action, including an interactive e-learning module on the role of B cells in the pathogenesis of RA
- A summary of what makes MabThera different from other RA treatments
- Summaries of the key clinical trials and related MabThera efficacy, safety and tolerability data
- A summary of the prescribing information
If you would like to view or download the MabThera SmPC or information resources for your patients, please go to the Resources section.